GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (FRA:NG2) » Definitions » Cyclically Adjusted FCF per Share

Neogen (FRA:NG2) Cyclically Adjusted FCF per Share : €0.33 (As of Feb. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Neogen Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Neogen's adjusted free cash flow per share for the three months ended in Feb. 2024 was €-0.267. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.33 for the trailing ten years ended in Feb. 2024.

During the past 12 months, Neogen's average Cyclically Adjusted FCF Growth Rate was -2.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 10.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Neogen was 44.20% per year. The lowest was 6.60% per year. And the median was 16.30% per year.

As of today (2024-05-24), Neogen's current stock price is €12.10. Neogen's Cyclically Adjusted FCF per Share for the quarter that ended in Feb. 2024 was €0.33. Neogen's Cyclically Adjusted Price-to-FCF of today is 36.67.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Neogen was 178.70. The lowest was 26.90. And the median was 113.99.


Neogen Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Neogen's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Cyclically Adjusted FCF per Share Chart

Neogen Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.29 0.30 0.40 0.36

Neogen Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.36 0.35 0.35 0.33

Competitive Comparison of Neogen's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Neogen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Neogen's Cyclically Adjusted Price-to-FCF falls into.



Neogen Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neogen's adjusted Free Cash Flow per Share data for the three months ended in Feb. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=-0.267/130.9299*130.9299
=-0.267

Current CPI (Feb. 2024) = 130.9299.

Neogen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201405 0.002 100.373 0.003
201408 0.060 100.352 0.078
201411 0.086 99.635 0.113
201502 0.070 99.032 0.093
201505 0.068 100.333 0.089
201508 0.034 100.548 0.044
201511 0.086 100.135 0.112
201602 0.034 100.040 0.044
201605 0.037 101.355 0.048
201608 0.148 101.617 0.191
201611 0.059 101.829 0.076
201702 0.081 102.779 0.103
201705 0.119 103.256 0.151
201708 0.117 103.587 0.148
201711 0.022 104.072 0.028
201802 0.103 105.052 0.128
201805 0.144 106.148 0.178
201808 0.116 106.383 0.143
201811 0.098 106.338 0.121
201902 0.044 106.649 0.054
201905 0.154 108.048 0.187
201908 0.147 108.245 0.178
201911 0.089 108.519 0.107
202002 0.141 109.139 0.169
202005 0.155 108.175 0.188
202008 0.166 109.662 0.198
202011 0.123 109.793 0.147
202102 0.025 110.968 0.029
202105 0.111 113.576 0.128
202108 0.172 115.421 0.195
202111 0.113 117.269 0.126
202202 -0.001 119.703 -0.001
202205 0.069 123.323 0.073
202208 -0.248 124.958 -0.260
202211 -0.140 125.607 -0.146
202302 -0.139 126.928 -0.143
202305 0.278 128.314 0.284
202308 -0.032 129.538 -0.032
202311 -0.037 129.548 -0.037
202402 -0.267 130.930 -0.267

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Neogen  (FRA:NG2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Neogen's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=12.10/0.33
=36.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Neogen was 178.70. The lowest was 26.90. And the median was 113.99.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Neogen Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Neogen's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen (FRA:NG2) Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Neogen (FRA:NG2) Headlines

No Headlines